Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.8 USD | -0.48% | +1.97% | -19.97% |
Sales 2024 * | 357M 28.56B | Sales 2025 * | 503M 40.27B | Capitalization | 3.68B 295B |
---|---|---|---|---|---|
Net income 2024 * | -723M -57.88B | Net income 2025 * | -672M -53.8B | EV / Sales 2024 * | 11.9 x |
Net Debt 2024 * | 553M 44.3B | Net Debt 2025 * | 654M 52.39B | EV / Sales 2025 * | 8.62 x |
P/E ratio 2024 * |
-5.38
x | P/E ratio 2025 * |
-6.34
x | Employees | 912 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.91% |
Latest transcript on Insmed Incorporated
1 day | -0.48% | ||
1 week | +1.97% | ||
Current month | -8.59% | ||
1 month | -8.22% | ||
3 months | -10.50% | ||
6 months | -2.94% | ||
Current year | -19.97% |
Managers | Title | Age | Since |
---|---|---|---|
Will Lewis
CEO | Chief Executive Officer | 55 | 09/09/12 |
Sara Bonstein
DFI | Director of Finance/CFO | 43 | 30/01/20 |
Martina Flammer
CTO | Chief Tech/Sci/R&D Officer | 60 | 18/12/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 31/03/20 |
Al Altomari
BRD | Director/Board Member | 65 | 01/08/12 |
Melvin Sharoky
BRD | Director/Board Member | 73 | 30/04/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.26% | 0 M€ | 0.00% | - | |
0.25% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 24.8 | -0.48% | 1,294,189 |
25/04/24 | 24.92 | -3.45% | 1,213,304 |
24/04/24 | 25.81 | +2.14% | 2,740,799 |
23/04/24 | 25.27 | +4.81% | 2,130,480 |
22/04/24 | 24.11 | -0.86% | 3,275,530 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.97% | 3.68B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- INSM Stock